EUVIMEDEUVIMED entdecken
Crossref

Benchmarking Gaussian processes for prediction and data assimilation of Alzheimer's disease progression

Pau Batlle, Matthieu Darcy, Matthew Levine, Boumediene Hamzi, Houman Owhadi, Mehrad Bastani, Yi Zhang, Khaled Sarsour, Francisco Talamas iD, CPAD Database

Journal of Alzheimer’s Disease · 2026

DOI: 10.1177/13872877251404082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2026. Verfasst von Pau Batlle und 9 weiteren Autor:innen. Beteiligte Einrichtung: California Institute of Technology, Pasadena, CA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Disease Progression, Benchmarking. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Johnson & Johnson Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ability to predict the trajectory of disease progression with high resolution for individual patients can enhance clinical trial design, enabling personalized, data-driven medical approaches. In this study, we deployed a kernel/Gaussian process-based dynamic model to predict Alzheimer's disease progression. Our numerical results demonstrate that the dynamic method outperforms static linear regression, improving the prediction of ADAS-Cog 11 subscores over extended periods by effectively incorporating intermediate data observations. This approach highlights the potential of computational models in enhancing clinical trial design and advancing personalized medicine for Alzheimer's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDisease ProgressionBenchmarkingHumansNormal DistributionMaleAged

Stichwörter der Autor:innen

Alzheimer’s diseaseGaussian processesdisease progressionkernel-based dynamical systemslinear regressionprecision medicine

Autor:innen und Institutionen

  • California Institute of Technology, Pasadena, CA, USA.
  • Eric and Wendy Schmidt Center, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • The Alan Turing Institute, London, UK.
  • Johnson & Johnson. Research & Development, Data Science and Digital Health, Raritan, NJ, USA.
  • N-Power Medicine, Redwood City, CA, USA.
  • Data used in the preparation of this article were obtained from the Critical Path for Alzheimer's Disease (CPAD) Database. In 2008, Critical Path Institute, in collaboration with the Engelberg Center for Health Care Ref…

ORCID-Profile: Francisco Talamas

Förderung

  • Johnson & Johnson Innovative Medicine

Zitieren

APA

Batlle, P., Darcy, M., Levine, M., Hamzi, B., Owhadi, H., Bastani, M., Zhang, Y., Sarsour, K., Talamas, F., & CPAD Database (2026). Benchmarking Gaussian processes for prediction and data assimilation of Alzheimer's disease progression. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251404082

Vancouver

Batlle P, Darcy M, Levine M, Hamzi B, Owhadi H, Bastani M, et al. Benchmarking Gaussian processes for prediction and data assimilation of Alzheimer's disease progression. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877251404082

BibTeX
@article{Batlle2026,
  author = {Batlle, Pau and Darcy, Matthieu and Levine, Matthew and Hamzi, Boumediene and Owhadi, Houman and Bastani, Mehrad and Zhang, Yi and Sarsour, Khaled and Talamas, Francisco and CPAD Database, CPAD Database},
  title = {Benchmarking Gaussian processes for prediction and data assimilation of Alzheimer's disease progression},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  doi = {10.1177/13872877251404082}
}
Kostenlos starten →